COVID-19 临床康复患者并发气管支气管曲霉病和支气管内曲霉菌瘤：一例罕见病例报告。
A rare case report of tracheobronchial aspergillosis with endobronchial aspergilloma in a patient clinically recovered from COVID-19.
机构信息
Department of Pulmonary Medicine, AIIMS, Patna, Bihar, India.
Department of Radiodiagnosis, AIIMS, Patna, Bihar, India.
出版信息
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):713-715. doi: 10.4103/ijpm.ijpm_780_21.
The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to an increased incidence of fungal infections. However, pulmonary infections are rare. COVID-associated pulmonary aspergillosis has been reported; however, there is no prior report of tracheobronchial aspergillosis with endobronchial aspergilloma as per the authors' literature search. We report such a case of a 65-year-old male with radiology and biopsy-proven endobronchial aspergilloma upon a background of tracheobronchial and pulmonary aspergillosis after having recovered clinically from severe COVID-19 disease.
新型冠状病毒病（COVID-19）是由严重急性呼吸综合征冠状病毒 2 引起的，导致真菌感染的发病率增加。然而，肺部感染较为罕见。有报道称与 COVID 相关的肺曲霉病；然而，据作者的文献检索，尚无先前报道的气管支气管曲霉病伴支气管内曲霉瘤。我们报告了这样一个病例，一名 65 岁男性，在 COVID-19 重症临床康复后，患有气管支气管和肺部曲霉病的基础上，经影像学和活检证实患有支气管内曲霉瘤。
Zotero 插件